Author

Madelyn Jean Abraham

Jewish General HospitalORCID 0009-0005-2884-6731Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 2 Assay:proteomics· 2 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Approach:experimental assay· 1 Assay:spatial transcriptomics· 1 Approach:statistical model· 1

Frequent Co-Authors

Christophe GonçalvesiD· 2 shared Sonia Victoria Del RinconiD· 2 shared Abdulhameed Abdulhamed· 1 shared Alanna Brewer· 1 shared Alexandre BenoitiD· 1 shared Amir HorowitziD· 1 shared Ashley Griffin· 1 shared Cynthia GuilbertiD· 1 shared

Activity by Year

2025-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 33 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

Christophe GonçalvesORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Cancer BiologybioRxivPreprintJun 1, 2026

B cell exhaustion associates with poor response to Bacillus Calmette-Guerin immunotherapy in patients with bladder cancer

Priyanka Yolmo, Kartik Sachdeva, Alanna Brewer…·Madhuri Koti

The paper identifies atypical B cells (ABCs) as mediators of poor response to BCG immunotherapy in high-risk NMIBC patients, linking their expansion and FCRL5 expression to early recurrence.

1 citation

humanspatial transcriptomics

𝕏 PostBluesky

Cancer BiologyCancer Immunology ResearchPeer-reviewedDec 29, 2025

The CCL17-CCR4 axis is critical for mutant STAT6-mediated microenvironmental remodelling and therapeutic resistance in Relapsed/Refractory Diffuse Large B Cell Lymphoma

Madelyn Jean Abraham, Cynthia Guilbert, Natascha Gagnon…·Koren Kathleen Mann

This study identifies the CCL17-CCR4 axis as a driver of therapeutic resistance in STAT6D419 mutant rrDLBCL by promoting T cell infiltration and microenvironmental changes.

DOI 10.1158/2326-6066.cir-25-0583

humanproteomics

𝕏 PostBluesky